Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores.

PURPOSE

To develop radiomics-based CT scores for assessing lung disease severity and exacerbation risk in adult patients with cystic fibrosis (CF).

MATERIALS AND METHODS

This two-center retrospective observational study was approved by an institutional ethics committee, and the need for patient consent was waived. A total of 215 outpatients with CF referred for unenhanced follow-up chest CT were evaluated in two different centers between January 2013 and December 2016. After lung segmentation, chest CT scans from center 1 (training cohort, 162 patients [median age, 29 years; interquartile range {IQR}, 24-36 years; 84 men]) were used to build CT scores from 38 extracted CT features, using five different machine learning techniques trained to predict a clinical prognostic score, the Nkam score. The correlations between the developed CT scores, two different clinical prognostic scores (Liou and CF-ABLE), forced expiratory volume in 1 second (FEV), and risk of respiratory exacerbations were evaluated in the test cohort (center 2, 53 patients [median age, 27 years; IQR, 22-35 years; 34 men]) using the Spearman rank coefficient.

RESULTS

In the test cohort, all radiomics-based CT scores showed moderate to strong correlation with the Nkam score ( = 0.57 to 0.63, < .001) and Liou scores ( = -0.55 to -0.65, < .001), whereas the correlation with CF-ABLE score was weaker ( = 0.28 to 0.38, = .005 to .048). The developed CT scores showed strong correlation with predicted FEV ( = -0.62 to -0.66, < .001) and weak to moderate correlation with the number of pulmonary exacerbations to occur in the 12 months after the CT examination ( = 0.38 to 0.55, < .001 to = .006).

CONCLUSION

Radiomics can be used to build automated CT scores that correlate to clinical severity and exacerbation risk in adult patients with CF.Supplemental material is available for this article.See also the commentary by Elicker and Sohn in this issue.© RSNA, 2020.